3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
9
fludarabine
5
zanubrutinib
3
Vincristine
3
Rituximab
3
Doxorubicin
3
pirtobrutinib
2
cemiplimab
2
Specimen Handling
2
Prednisone
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Dexamethasone
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
acalabrutinib
1
X-Rays
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.